Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: A report of 2 cases
- 1 December 2004
- journal article
- case report
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 44 (6) , 1097-1102
- https://doi.org/10.1053/j.ajkd.2004.08.032
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Linezolid in the treatment of vancomycin‐resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate‐use trialTransplant Infectious Disease, 2003
- Pharmacokinetics of Linezolid in Subjects with Renal DysfunctionAntimicrobial Agents and Chemotherapy, 2003
- Linezolid Clearance During Continuous Venovenous Hemodiafiltration: A Case ReportPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infectionsJournal of Antimicrobial Chemotherapy, 2003
- Safety and tolerability of linezolidJournal of Antimicrobial Chemotherapy, 2003
- Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone AntibacterialClinical Pharmacokinetics, 2003
- Pharmacological Principles of Antibiotic Prescription in the Critically IllAnaesthesia and Intensive Care, 2002
- Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patientsActa Anaesthesiologica Scandinavica, 2001
- Pharmacokinetic principles during continuous renal replacement therapy: Drugs and dosageKidney International, 1999
- Determination of linezolid in plasma by reversed-phase high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1999